Work

Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced HER-2/NEU activation, receptor expression and proliferation of HER-2-positive malignant cell lines

Year: 1997

Type: article

Source: International Journal of Cancer

DOI: 10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l

Authors: Frank Hartmann, Eva M. Horak, Cheryl Cho, Ruth Lupu, Joseph B. Bolen, Mary A. Stetler-Stevenson, Michael Pfreundschuh, Thomas A. Waldmann, Ivan D. Horak

Institutions: National Institutes of Health, Universitätsklinikum des Saarlandes, National Cancer Institute, Georgetown University Medical Center, Lawrence Berkeley National Laboratory, University of California, Berkeley

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1970631761

FWCI: 3.018

Cites: 31

Cited by: 47

Related to: 10